drugset / Trial / NCT00527592

A Single Dose Comfort Comparison of Travatan Z in One Eye Versus Xalatan in the Opposite Eye in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension

NCT00527592

Phase 4 Completed 54 enrolled Alcon Research
RandomizedSingle-groupDouble-blindTreatment

Summary

The purpose of this study is to compare the comfort of Travatan Z in one eye and Xalatan in the opposite eye in patients with primary open-angle glaucoma or ocular hypertension.

Timeline

Start
2007-05
Primary completion
2008-08
Completion
2008-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Latanoprost Small molecule 0.005 % Other
Subject Travoprost Other / unclassified 0.004 % Other